No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RGEN250117C150000
- 7.52
- +0.82+12.24%
15min DelayClose Dec 20 16:00 ET
7.52High7.52Low
7.52Open6.70Pre Close2 Volume39 Open Interest150.00Strike Price1.50KTurnover51.64%IV9.04%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry7.52Extrinsic Value100Contract SizeAmericanOptions Type0.4263Delta0.0199Gamma25.34Leverage Ratio-0.1599Theta0.0389Rho10.80Eff Leverage0.1495Vega
Intraday
- 5D
- Daily
News
Repligen Corporation (RGEN) Fell Along With Peers
Repligen Initiated at Hold by Canaccord Genuity
Repligen Analyst Ratings
CCORF Initiates Repligen(RGEN.US) With Hold Rating, Announces Target Price $165
Express News | BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors
Press Release: BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors